Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Anteris Technologies is a medical device company specializing in innovative transcatheter aortic valve replacement (TAVR) systems. Its flagship product, DurAVR, features a biomimetic, single-piece design with proprietary ADAPT tissue technology for enhanced durability and hemodynamics. The company targets the global cardiovascular market, focusing on treating aortic stenosis with minimally invasive solutions that aim to improve patient outcomes and valve longevity.
This description was generated via AI from an annual report. Updated about 1 year ago.